Pain
Conditions
Brief summary
• Proportion of participants with VAS≥30 mm (0-100mm)
Detailed description
• • Max electronic Visual Analog Scale (VAS) pain (0-100 mm), • Max Numeric Rating Scale (NRS) pain (0-10), • Time (seconds) to max electronic Visual Analog Scale (VAS) pain, • Area under the curve (AUC) 0-1 min, 1-2 min, 2-3 min, • Area under the curve VAS≥30 (AUCVAS≥30) 0-1 min, 1-2 min, 2-3 min, • Curve shape of electronic Visual Analog Scale (VAS) pain (0-100 mm) by description of the curve (number of peaks), • Max Numeric Rating Scale (NRS) pain (0-10), • Richmond Agitation-Sedation Scale (RASS)
Interventions
Sponsors
Oslo University Hospital HF
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| • Proportion of participants with VAS≥30 mm (0-100mm) | — |
Secondary
| Measure | Time frame |
|---|---|
| • • Max electronic Visual Analog Scale (VAS) pain (0-100 mm), • Max Numeric Rating Scale (NRS) pain (0-10), • Time (seconds) to max electronic Visual Analog Scale (VAS) pain, • Area under the curve (AUC) 0-1 min, 1-2 min, 2-3 min, • Area under the curve VAS≥30 (AUCVAS≥30) 0-1 min, 1-2 min, 2-3 min, • Curve shape of electronic Visual Analog Scale (VAS) pain (0-100 mm) by description of the curve (number of peaks), • Max Numeric Rating Scale (NRS) pain (0-10), • Richmond Agitation-Sedation Scale (RASS) | — |
Countries
Norway
Outcome results
None listed